Pharmacokinetics and Bioequivalence Study of HMPL-523 Acetate Tablets in Humans
NCT07331194
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
54
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
HMPL-523 Acetate Tablets (Test Formulation)
DRUG:
HMPL-523 Acetate Tablets (Reference Formulation)
Sponsor
Hutchmed